“…It has been suggested that some of the metabolic abnormalities in thyroid disease may be secondary to alterations in the metabolism of adenosine 3':5'-cyclic monophosphate (cyclic AMP) in tissues (Krishna, Hynie & Brodie, 1968;Levey, Skelton & Epstein, 1969a;Caldwell & Fain, 1971). Investigations of this type have largely been concerned with heart and adipose tissue of experimental animals, although metabolic changes have also been studied in the liver in thyroid disease (Freedland, 1965;Dooner, Parada, Aliaga & Hoyl, 1967;Klion, Segal & Schaffner, 1971).…”